Vyome Holdings, Inc. (NASDAQ:HIND) — Market Cap & Net Worth
Market Cap & Net Worth: Vyome Holdings, Inc. (HIND)
Vyome Holdings, Inc. (NASDAQ:HIND) has a market capitalization of $11.06 Million ($11.06 Million) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #26621 globally and #5313 in its home market, demonstrating a -13.27% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vyome Holdings, Inc.'s stock price $1.96 by its total outstanding shares 5644494 (5.64 Million). Analyse cash efficiency ratio of Vyome Holdings, Inc. to see how efficiently the company converts income to cash.
Vyome Holdings, Inc. Market Cap History: 2025 to 2026
Vyome Holdings, Inc.'s market capitalization history from 2025 to 2026. Data shows growth from $19.42 Million to $11.06 Million (0.00% CAGR).
Vyome Holdings, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vyome Holdings, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of HIND by Market Capitalization
Companies near Vyome Holdings, Inc. in the global market cap rankings as of May 4, 2026.
Key companies related to Vyome Holdings, Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
- UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.56 Billion | $423.92 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.88 Billion | $701.42 |
| #517 | UCB SA | BR:UCB | $51.45 Billion | €231.20 |
| #568 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
Vyome Holdings, Inc. Historical Marketcap From 2025 to 2026
Between 2025 and today, Vyome Holdings, Inc.'s market cap moved from $19.42 Million to $ 11.06 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $11.06 Million | -43.02% |
| 2025 | $19.42 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Vyome Holdings, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.06 Million USD |
| MoneyControl | $11.06 Million USD |
| MarketWatch | $11.06 Million USD |
| marketcap.company | $11.06 Million USD |
| Reuters | $11.06 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Vyome Holdings, Inc.
Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Cambridge, Massachusetts.